Skip to main content

Table 1 Demographic and clinical characteristics of the included patients

From: Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial

Variables TXA study group (n = 37) NS study group (n = 40) P value
Female (%) 32 (82.05) 33 (80.49) 0.86
Age (year) 77.80 ± 9.75 79.18 ± 6.50 0.54*
BMI 23.79 ± 2.18 23.27 ± 2.93 0.61*
Side (right/left) 18/19 21/19 0.74
Preop. hemoglobin level (g/L) 109.50 ± 15.07 112.15 ± 13.31 0.51
Preop. hematocrit level (%) 32.63 ± 4.28 33.79 ± 3.83 0.31
Preop. transfusion (mL) 220.00 ± 354.80 158.00 ± 315.30 0.51
AO fracture classification
 31 A1 14 14 0.76
 31 A2 11 15
 31 A3 12 11
ASA classification
 I 5 4 0.89^
 II 16 18
 III 16 18
 IV 2 1
Operative time (min) 81.90 ± 25.61 80.67 ± 29.44 0.88*
Hospital stay (days) 8.10 ± 1.74 9.03 ± 2.10 0.10*
  1. *Two-sided student’s t test; chi-squared test; ^non-parametric test; TXA tranexamic acid, NS normal-saline, BMI body mass index